已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China

医学 羟基氯喹 内科学 临床终点 随机对照试验 系统性红斑狼疮 疾病 传染病(医学专业) 2019年冠状病毒病(COVID-19)
作者
Yunyun Fei,Lidan Zhao,Lijun Wu,Xiaoxia Zuo,Rongli Li,Jiaomei Cheng,Hui Luo,Xue Wu,Li Yan Sun,Jingjing Xu,Yingxuan Zhu,Yang Wang,Zhu Chen,Xiaomei Li,Xiaofei Wang,Xuan Zhang
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:84 (2): 274-283 被引量:17
标识
DOI:10.1136/ard-2024-225826
摘要

Objectives

To explore the relapse rate after glucocorticoid (GC) withdrawal with or without hydroxychloroquine (HCQ) maintenance in sustained clinically inactive systemic lupus erythematosus (SLE).

Methods

The PRESS trial is a multicentre, 33-week, open-label, three-arm, non-inferiority designed, randomised controlled trial. SLE patients with sustained clinically inactive disease who were maintained on low-dose GC plus HCQ therapy were screened and qualified patients were randomly assigned to three groups: drug-free group (both GC and HCQ withdrawal); HCQ group (discontinued GC but maintained HCQ); dual maintenance group (both GC and HCQ continued). The primary endpoint was to compare the proportion of patients experiencing a relapse as defined by the Safety of Estrogens in Lupus Erythematosus National Assessment-Systemic Lupus Erythematosus Disease Activity Index flare index by 33 weeks. Two parallel non-inferiority analyses were performed (drug-free group vs dual maintenance group and HCQ group vs dual maintenance group).

Results

From 3 November 2016 to 13 August 2021, 333 participants complied with the protocol after randomisation were analysed. The relapse rates in the three groups were 26.1%, 11.2% and 4.7%, respectively. Compared with dual maintenance group, drug-free group failed to achieve non-inferiority significance (relapse rate difference 21.4%; 95% CI 12.3% to 30.5%; Pnon-inferiority=0.238), whereas HCQ group achieved non-inferiority (relapse rate difference 6.5%; 95% CI −0.5% to 13.5%; Pnon-inferiority=0.034). HCQ group also exhibited fewer relapses than drug-free group (p=0.006). Adverse events were similar among all three groups.

Conclusions

GC withdrawal may be feasible in sustained clinically inactive SLE patients. HCQ maintenance can exert a protective role in preventing disease relapse after GC withdrawal.

Trial registration number

NCT02842814.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
小波发布了新的文献求助30
2秒前
浩whu完成签到,获得积分10
3秒前
七叶花开完成签到,获得积分10
4秒前
奥特曼打小人的应助被YIDAN采纳,获得20
4秒前
rin382发布了新的文献求助50
4秒前
冰魄落叶完成签到,获得积分10
5秒前
5秒前
华无剑的应助被萧雨墨采纳,获得10
5秒前
念槿完成签到,获得积分10
6秒前
健壮的含卉完成签到 ,获得积分10
7秒前
7秒前
10秒前
111完成签到,获得积分10
11秒前
打打的应助被好幸运采纳,获得10
12秒前
zhou完成签到,获得积分10
12秒前
QY发布了新的文献求助10
12秒前
LWY发布了新的文献求助10
13秒前
14秒前
夜月残阳完成签到,获得积分0
15秒前
btsforever完成签到,获得积分10
15秒前
1111完成签到,获得积分10
15秒前
16秒前
小波完成签到,获得积分20
16秒前
18秒前
粒粒完成签到,获得积分10
19秒前
ffff完成签到 ,获得积分0
21秒前
22秒前
23秒前
dzy完成签到,获得积分10
23秒前
23秒前
23秒前
先生先生你怎么了完成签到,获得积分10
24秒前
贺靖巧发布了新的文献求助10
25秒前
YIDAN完成签到,获得积分10
26秒前
刘伟完成签到,获得积分20
26秒前
光亮静槐完成签到 ,获得积分10
26秒前
27秒前
28秒前
momo完成签到 ,获得积分10
29秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158391
求助须知:如何正确求助?哪些是违规求助? 9554206
关于积分的说明 21718287
捐赠科研通 7747762
什么是DOI,文献DOI怎么找? 3426964
关于科研通互助平台的介绍 2551704
邀请新用户注册赠送积分活动 2471132